Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johji Inazawa

Showing results (1-10 of 226) with videos related to

Pageof 23
Sort By:
Journal of Human Genetics|June 5, 2021
Cancer-associated miRNAs and their therapeutic potentialJun Inoue, Johji Inazawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 12, 2005
[Exploration of novel molecular targets for cancer therapy based on genomic aberrations]Issei Imoto, Johji Inazawa
Cancer Science|February 11, 2012
Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cellsKen-ichi Kozaki, Johji Inazawa
Cancer Medicine|October 22, 2019
Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome AtlasKousuke Tanimoto, Tomoki Muramatsu, Johji Inazawa
Molecular Cancer Research : MCR|January 14, 2021
Suppression of MET Signaling Mediated by Pitavastatin and Capmatinib Inhibits Oral and Esophageal Cancer Cell GrowthBo Xu, Tomoki Muramatsu, Johji Inazawa
Cancer Science|July 13, 2004
Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genesJohji Inazawa, Jun Inoue, Issei Imoto
Human Genetics|March 15, 2021
A missense variant in NUF2, a component of the kinetochore NDC80 complex, causes impaired chromosome segregation and aneuploidy associated with microcephaly and short statureDaniela Tiaki Uehara, Hiroshi Mitsubuchi, Johji Inazawa
Cancer Research|August 6, 2021
miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4Yasuyuki Gen, Tomoki Muramatsu, Jun Inoue, et al.
Oncotarget|April 9, 2016
Down-regulation of LAPTM5 in human cancer cellsMichelle Nuylan, Tatsuyuki Kawano, Johji Inazawa, et al.
Cancer Science|August 30, 2018
Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell lineTaku Sato, Tomoki Muramatsu, Minoru Tanabe, et al.
Pageof 23

Showing results (1-10 of 226) with videos related to

Sort By:
Pageof 23
Journal of Human Genetics|June 5, 2021
Cancer-associated miRNAs and their therapeutic potentialJun Inoue, Johji Inazawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 12, 2005
[Exploration of novel molecular targets for cancer therapy based on genomic aberrations]Issei Imoto, Johji Inazawa
Cancer Science|February 11, 2012
Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cellsKen-ichi Kozaki, Johji Inazawa
Cancer Medicine|October 22, 2019
Massive computational identification of somatic variants in exonic splicing enhancers using The Cancer Genome AtlasKousuke Tanimoto, Tomoki Muramatsu, Johji Inazawa
Molecular Cancer Research : MCR|January 14, 2021
Suppression of MET Signaling Mediated by Pitavastatin and Capmatinib Inhibits Oral and Esophageal Cancer Cell GrowthBo Xu, Tomoki Muramatsu, Johji Inazawa
Cancer Science|July 13, 2004
Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genesJohji Inazawa, Jun Inoue, Issei Imoto
Human Genetics|March 15, 2021
A missense variant in NUF2, a component of the kinetochore NDC80 complex, causes impaired chromosome segregation and aneuploidy associated with microcephaly and short statureDaniela Tiaki Uehara, Hiroshi Mitsubuchi, Johji Inazawa
Cancer Research|August 6, 2021
miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4Yasuyuki Gen, Tomoki Muramatsu, Jun Inoue, et al.
Oncotarget|April 9, 2016
Down-regulation of LAPTM5 in human cancer cellsMichelle Nuylan, Tatsuyuki Kawano, Johji Inazawa, et al.
Cancer Science|August 30, 2018
Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell lineTaku Sato, Tomoki Muramatsu, Minoru Tanabe, et al.
Pageof 23